Johnson & Johnson has unveiled groundbreaking findings on nipocalimab, an investigational FcRn blocker, in a recent ...

Results from a new study published in Clinical and Translational Immunology found that dual-target antibody therapy can enhance cancer-fighting T cells more effectively than current single-target ...

Researchers say study provides sufficient rationale to further explore the therapeutic uses of SSRIs during infection.

The company, helmed by BioNTech alums, is developing therapies aimed at dermatological, respiratory and gut-related ...

In this part of his Pharmaceutical Executive video interview, Ian Chan, CEO of Abpro discusses the advantages of their DiversImmune and MultiMab platforms for antibody discovery and engineering.

Guillain-Barré Syndrome occurs when the body’s immune system mistakenly attacks nerve cells, disrupting communication between ...

Getty ImagesA team of researchers have made a new discovery in the field of hematology, providing an explanation for spontaneous and unusual ...

The best way to stay protected against measles is to get vaccinated, according to experts. The measles, mumps and rubella (MMR) vaccine is 93% effective against measles after one dose and 97% ...

The development of bacterial vaccines has played a critical role in combating infectious diseases, significantly reducing mortality and morbidity worldwide.

Vaccinations alone may not be enough to protect people with compromised immune systems from infection, even if the vaccine has generated the production of antibodies, new research from the University ...

A team of researchers have made a new discovery in the field of hematology, providing an explanation for spontaneous and ...

Pemphigus is a rare autoimmune disease that causes painful blisters on the skin and mucous membranes, including the mouth, ...